PDCD1 and skin squamous cell carcinoma: Anti-programmed cell death protein 1 (PD-1) antibody drugs, Cemiplimab (Cem), and Pembrolizumab (Pem) are indicated for the treatment of locally advanced and metastatic cSCC.